Indeed, H2afy has been selectively implicated as a risk factor and marker of disease progression in Huntington’s disease both in humans and mouse models11, suggesting a potential isoform-specific relevance of mH2A in neurodegeneration. The gene discussed is MACROH2A1; the disease is juvenile Huntington disease.